Design of a Synthetic Long Peptide Vaccine Targeting HPV-16 and -18 Using Immunoinformatic Methods

Human papillomavirus types 16 and 18 cause the majority of cervical cancers worldwide. Despite the availability of three prophylactic vaccines based on virus-like particles (VLP) of the major capsid protein (L1), these vaccines are unable to clear an existing infection. Such infected persons experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Tîrziu, Alexandru, Avram, Speranța, Madă, Leonard, Crișan-Vida, Mihaela, Popovici, Casiana, Popovici, Dan, Faur, Cosmin, Duda-Seiman, Corina, Păunescu, Virgil, Vernic, Corina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384861/
https://www.ncbi.nlm.nih.gov/pubmed/37513985
http://dx.doi.org/10.3390/pharmaceutics15071798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384861/
https://www.ncbi.nlm.nih.gov/pubmed/37513985
http://dx.doi.org/10.3390/pharmaceutics15071798

Ejemplares similares